ProfileGDS4718 / 207482_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 68% 60% 67% 65% 60% 64% 70% 70% 67% 62% 65% 64% 62% 59% 64% 64% 63% 65% 71% 67% 61% 63% 65% 63% 62% 64% 59% 67% 66% 63% 60% 70% 65% 62% 58% 64% 64% 64% 59% 64% 64% 59% 59% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3254763
GSM549102patient 115, normal, homogenized [OPG study]6.6598668
GSM549104patient 119, normal, homogenized [OPG study]6.1781660
GSM549108patient 138, normal, homogenized [OPG study]6.6358167
GSM549119patient 077, normal, homogenized [OPG study]6.4592565
GSM549133patient 032, cancer, homogenized [OPG study]6.0838260
GSM549139patient 042, cancer, homogenized [OPG study]6.4420164
GSM549099patient 107, normal, homogenized [OPG study]6.7924870
GSM549109patient 139, normal, homogenized [OPG study]6.8300270
GSM549110patient 046, normal, homogenized [OPG study]6.5962267
GSM549114patient 063, normal, homogenized [OPG study]6.2369262
GSM549122patient 082, normal, homogenized [OPG study]6.5047365
GSM549134patient 033, cancer, homogenized [OPG study]6.4005664
GSM549136patient 036, cancer, homogenized [OPG study]6.2128762
GSM549140patient 044, cancer, homogenized [OPG study]6.0112759
GSM549111patient 047, normal, homogenized [OPG study]6.4387164
GSM549113patient 057, normal, homogenized [OPG study]6.4220364
GSM549132patient 031, cancer, homogenized [OPG study]6.3052863
GSM549137patient 038, cancer, homogenized [OPG study]6.4582965
GSM549142patient 047, cancer, homogenized [OPG study]6.9041171
GSM549100patient 110, normal, homogenized [OPG study]6.5925467
GSM549107patient 135, normal, homogenized [OPG study]6.1790861
GSM549115patient 068, normal, homogenized [OPG study]6.3285463
GSM549116patient 072, normal, homogenized [OPG study]6.5135165
GSM549120patient 078, normal, homogenized [OPG study]6.3427763
GSM549131patient 030, cancer, homogenized [OPG study]6.2684162
GSM549118patient 074, normal, homogenized [OPG study]6.4372764
GSM549129patient 027, cancer, homogenized [OPG study]6.1001959
GSM549123patient 088, normal, homogenized [OPG study]6.6342167
GSM549124patient 006, cancer, homogenized [OPG study]6.5528166
GSM549126patient 015, cancer, homogenized [OPG study]6.351463
GSM549128patient 025, cancer, homogenized [OPG study]6.117660
GSM549103patient 117, normal, homogenized [OPG study]6.8509970
GSM549117patient 073, normal, homogenized [OPG study]6.4339465
GSM549138patient 041, cancer, homogenized [OPG study]6.2745862
GSM549141patient 045, cancer, homogenized [OPG study]5.9608358
GSM549130patient 028, cancer, homogenized [OPG study]6.3670864
GSM549101patient 111, normal, homogenized [OPG study]6.4156964
GSM549105patient 128, normal, homogenized [OPG study]6.4141264
GSM549106patient 134, normal, homogenized [OPG study]6.0660159
GSM549112patient 048, normal, homogenized [OPG study]6.4304664
GSM549125patient 011, cancer, homogenized [OPG study]6.3742464
GSM549127patient 024, cancer, homogenized [OPG study]6.1164359
GSM549135patient 035, cancer, homogenized [OPG study]6.0750259